ProShare Investment Clubs

BTG Overview

BTG is a specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. The company is also seeking to acquire new products to develop and market to hospital specialists.

1 Day Chart

6 Month Chart

More BTG charts

BTG Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Mar-09	84.80	(11.30)	1.10p	112.7	n/a	-90%	n/a	0.0%
31-Mar-10	98.50	9.10	6.90p	25.8	0.0	+527%	n/a	0.0%
31-Mar-11	111.40	(10.80)	1.00p	227.6	n/a	-86%	n/a	0.0%
31-Mar-12	197.00	23.00	11.40p	29.3	0.0	+1,040%	n/a	0.0%
31-Mar-13	233.70	24.10	14.50p	24.6	0.9	+27%	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

BTG Forecasts

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Mar-14	233.37	51.13	13.22p	25.6	n/a	-9%	n/a	0.0%
31-Mar-15	276.55	78.86	19.87p	17.0	0.3	+50%	0.20p	0.1%

BTG forecasts

BTG Company Announcements

Final Results	20-May-2013	07:00	RNS
Total Voting Rights	30-Apr-2013	11:50	RNS
Holding(s) in Company	15-Apr-2013	17:07	RNS

More btg company announcements

BTG ShareCast News

Tuesday broker round-up UPDATE	21-May-2013	ShareCast
FTSE 250 movers: FirstGroup plunges after cancel...	20-May-2013	ShareCast
BTG upbeat as full year profit rises	20-May-2013	ShareCast

More BTG ShareCast news

BTG Top Newspaper Links

Protherics slithers into the grasp of BTG as new...	19-Sep-2008	Times
BTG buy to go big	19-Sep-2008	Sun
Biotech boss Brown takes chair at BTG	09-Dec-2007	Scotland on Sunday

Latest BTG Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

Price Data

Currency	UK Pounds
Share Price	337.70p
Change Today	-0.90p
% Change	-0.27 %
Volume	449,537
20-May-13 Close	338.60p
Shares Issued	328.29m
Market Cap	£1,108.65m
Year End	31-Mar-13

What The Brokers Say

Strong Buy	4
Buy	0
Neutral	5
Sell	0
Strong Sell	0
Total	9

Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Latest recommendations

Broker consensus analysis

BTG Dividends

No dividends found

Trades for 21-May-2013

Time	Volume / Share Price
13:03	126 @ 337.70p
13:03	250 @ 337.70p
13:03	592 @ 337.70p
13:03	1,032 @ 337.70p
13:02	290 @ 338.23p

More BTG trades data

BTG Key Personnel

CEO	Louise Makin
CFO	Rolf Soderstrom

More BTG corporate information